Literature DB >> 31558257

Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar.

Dave L Dixon1, Garima Sharma2, Pratik B Sandesara3, Eugene Yang4, Lynne T Braun5, George A Mensah6, Laurence S Sperling7, Prakash C Deedwania8, Salim S Virani9.   

Abstract

Entities:  

Keywords:  guidelines; implementation science; inertia

Year:  2019        PMID： 31558257     DOI： 10.1016/j.jacc.2019.08.014

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.

Authors:  Dhruv Mahtta; David J Ramsey; Michelle T Lee; Liang Chen; Mahmoud Al Rifai; Julia M Akeroyd; Elizabeth M Vaughan; Michael E Matheny; Karla Rodrigues do Espirito Santo; Sankar D Navaneethan; Carl J Lavie; Yochai Birnbaum; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

2.  Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018.

Authors:  Alexander R Zheutlin; Catherine G Derington; Jordan B King; Ransmond O Berchie; Jennifer S Herrick; Dave L Dixon; Jordana B Cohen; Daichi Shimbo; Ian M Kronish; Joseph J Saseen; Paul Muntner; Andrew E Moran; Adam P Bress
Journal:  Am Heart J       Date:  2021-10-16       Impact factor: 5.099

Review 3.  Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures?

Authors:  Matthew R Deshotels; Salim S Virani; Christie M Ballantyne
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

Review 4.  Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction.

Authors:  Stephen J Greene; Xi Tan; Yu-Chen Yeh; Mark Bernauer; Omer Zaidi; Mei Yang; Javed Butler
Journal:  Heart Fail Rev       Date:  2021-01-20       Impact factor: 4.214

5.  Cause of Death After Surgical Aortic Valve Replacement: SWEDEHEART Observational Study.

Authors:  Natalie Glaser; Michael Persson; Anders Franco-Cereceda; Ulrik Sartipy
Journal:  J Am Heart Assoc       Date:  2021-11-08       Impact factor: 5.501

6.  Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.

Authors:  Rohini Mathur; Ruth E Farmer; Sophie V Eastwood; Nish Chaturvedi; Ian Douglas; Liam Smeeth
Journal:  PLoS Med       Date:  2020-05-15       Impact factor: 11.069

7.  Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.

Authors:  Sarah T Ahmed; Julia M Akeroyd; Dhruv Mahtta; Richard Street; Jason Slagle; Ann Marie Navar; Neil J Stone; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  J Am Heart Assoc       Date:  2020-11-10       Impact factor: 5.501

8.  Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.

Authors:  Dhruv Mahtta; David J Ramsey; Mahmoud Al Rifai; Khurram Nasir; Zainab Samad; David Aguilar; Hani Jneid; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  JAMA Netw Open       Date:  2020-08-03

Review 9.  Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations.

Authors:  David I Feldman; Erin D Michos; Neil J Stone; Ty J Gluckman; Miguel Cainzos-Achirica; Salim S Virani; Roger S Blumenthal
Journal:  Am J Prev Cardiol       Date:  2020-11-13

10.  Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease.

Authors:  Glenn T Gobbel; Michael E Matheny; Ruth R Reeves; Julia M Akeroyd; Alexander Turchin; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  Am J Prev Cardiol       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.